Nanogel-Based Immunologically Stealth Vaccine Targets Macrophages in the Medulla of Lymph Node and Induces Potent Antitumor Immunity
- 2 September 2014
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 8 (9) , 9209-9218
Abstract
Because existing therapeutic cancer vaccines provide only a limited clinical benefit, a different vaccination strategy is necessary to improve vaccine efficacy. We developed a nanoparticulate cancer vaccine by encapsulating a synthetic long peptide antigen within an immunologically inert nanoparticulate hydrogel (nanogel) of cholesteryl pullulan (CHP). After subcutaneous injection to mice, the nanogel-based vaccine was efficiently transported to the draining lymph node, and was preferentially engulfed by medullary macrophages but was not sensed by other macrophages and dendritic cells (so-called “immunologically stealth mode”). Although the function of medullary macrophages in T cell immunity has been unexplored so far, these macrophages effectively cross-primed the vaccine-specific CD8+ T cells in the presence of a Toll-like receptor (TLR) agonist as an adjuvant. The nanogel-based vaccine significantly inhibited in vivo tumor growth in the prophylactic and therapeutic settings, compared to another vaccine formulation using a conventional delivery system, incomplete Freund’s adjuvant. We also revealed that lymph node macrophages were highly responsive to TLR stimulation, which may underlie the potency of the macrophage-oriented, nanogel-based vaccine. These results indicate that targeting medullary macrophages using the immunologically stealth nanoparticulate delivery system is an effective vaccine strategy.Keywords
Funding Information
- Japan Society for the Promotion of Science
- Japan Science and Technology Agency
This publication has 37 references indexed in Scilit:
- Nonagonistic Dectin-1 ligand transforms CpG into a multitask nanoparticulate TLR9 agonistProceedings of the National Academy of Sciences, 2014
- Forkhead box transcription factor 1 expression in gastric cancer: FOXM1 is a poor prognostic factor and mediates resistance to docetaxelJournal of Translational Medicine, 2013
- Peripherally Administered Nanoparticles Target Monocytic Myeloid Cells, Secondary Lymphoid Organs and Tumors in MicePLOS ONE, 2013
- CD8− Dendritic Cells and Macrophages Cross-Present Poly(D,L-lactate-co-glycolate) Acid Microsphere-Encapsulated Antigen In VivoThe Journal of Immunology, 2011
- CD169-Positive Macrophages Dominate Antitumor Immunity by Crosspresenting Dead Cell-Associated AntigensImmunity, 2011
- TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responsesVaccine, 2008
- Exploiting lymphatic transport and complement activation in nanoparticle vaccinesNature Biotechnology, 2007
- CELL BIOLOGY OF ANTIGEN PROCESSING IN VITRO AND IN VIVOAnnual Review of Immunology, 2005
- Microscopic Structure and Thermoresponsiveness of a Hydrogel Nanoparticle by Self-Assembly of a Hydrophobized PolysaccharideMacromolecules, 1997
- Self-aggregates of hydrophobized polysaccharides in water. Formation and characteristics of nanoparticlesMacromolecules, 1993